piracetam has been researched along with Anterior Choroidal Artery Infarction in 15 studies
Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This article investigated the clinical effects of piracetam with nimodipine in the treatment of vascular dementia (VD) after cerebral infarction." | 7.96 | Therapeutic effect of piracetam with nimodipine on vascular dementia after cerebral infarction. ( Lei, Z; Wenjing, L; Zhaomin, C; Zongfang, Z, 2020) |
| "GABA and Piracetam caused the improvement of the morphological state of cerebral infarction, due to intracarotid infusion of Arachidonic acid." | 7.68 | [Effects of GABA and piracetam on the development of experimental cerebral infarction in rats and platelet aggregation in patients with cerebrovascular disorders]. ( Amroian, EA; Balian, LS; Parsamian, LK; Vartazarian, ND, 1990) |
| "This article investigated the clinical effects of piracetam with nimodipine in the treatment of vascular dementia (VD) after cerebral infarction." | 3.96 | Therapeutic effect of piracetam with nimodipine on vascular dementia after cerebral infarction. ( Lei, Z; Wenjing, L; Zhaomin, C; Zongfang, Z, 2020) |
| "In this study, the temporal development of focal cerebral infarction induced by permanent middle cerebral artery occlusion (pMCAO) and the effects of piracetam, a derivative of gamma-aminobutyric acid widely used in clinical practice as a nootropic agent, on infarct area and volume were investigated." | 3.71 | The 2-oxopyrrolidinacetamide piracetam reduces infarct brain volume induced by permanent middle cerebral artery occlusion in male rats. ( Amoroso, S; Annunziato, L; DiRenzo, G; Minale, M; Pignataro, G; Tortiglione, A, 2002) |
| "GABA and Piracetam caused the improvement of the morphological state of cerebral infarction, due to intracarotid infusion of Arachidonic acid." | 3.68 | [Effects of GABA and piracetam on the development of experimental cerebral infarction in rats and platelet aggregation in patients with cerebrovascular disorders]. ( Amroian, EA; Balian, LS; Parsamian, LK; Vartazarian, ND, 1990) |
| "Seizures are rare manifestation of thalamic disorder." | 1.46 | Unilateral Thalamic Infarct Presenting as a Convulsive Seizure. ( Brohi, H; Kumar, R; Mughul, A, 2017) |
| "Treatment with oxiracetam (400 mg/kg/d p." | 1.28 | Effect of oxiracetam on cerebrovascular impairment in rats. ( Hasegawa, Y; Inukai, T; Kometani, M; Nakao, N; Okada, M; Takemori, E, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (6.67) | 18.7374 |
| 1990's | 5 (33.33) | 18.2507 |
| 2000's | 6 (40.00) | 29.6817 |
| 2010's | 2 (13.33) | 24.3611 |
| 2020's | 1 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Zongfang, Z | 1 |
| Wenjing, L | 1 |
| Zhaomin, C | 1 |
| Lei, Z | 1 |
| Kumar, R | 1 |
| Brohi, H | 1 |
| Mughul, A | 1 |
| Ali, K | 1 |
| Derev'yannykh, EA | 1 |
| Bel'skaya, GN | 1 |
| Knoll, EA | 1 |
| Krylova, LG | 1 |
| Popov, DV | 1 |
| Tortiglione, A | 1 |
| Minale, M | 1 |
| Pignataro, G | 1 |
| Amoroso, S | 1 |
| DiRenzo, G | 1 |
| Annunziato, L | 1 |
| Xerri, C | 1 |
| Zennou-Azogui, Y | 1 |
| Zhong, SQ | 1 |
| Sun, LJ | 1 |
| Yan, YZ | 1 |
| Sun, YQ | 1 |
| Zhong, YY | 1 |
| Chan, S | 1 |
| Ros, S | 1 |
| You, KY | 1 |
| Nhem, S | 1 |
| Salle, JY | 1 |
| Dudognon, P | 1 |
| Daviet, JC | 1 |
| Dierckx, RA | 1 |
| Dobbeleir, A | 1 |
| Pickut, BA | 1 |
| Timmermans, L | 1 |
| Dierckx, I | 1 |
| Vervaet, A | 1 |
| Vandevivere, J | 1 |
| Deberdt, W | 2 |
| De Deyn, PP | 1 |
| Enderby, P | 1 |
| Broeckx, J | 1 |
| Hospers, W | 1 |
| Schildermans, F | 1 |
| Rösel, T | 1 |
| Schneider, J | 1 |
| Fischer, JT | 1 |
| Druschky, KF | 1 |
| Kawiak, W | 1 |
| Pilarczyk, M | 1 |
| Chmielewska, B | 1 |
| Gieracz-Nazar, A | 1 |
| Kometani, M | 1 |
| Okada, M | 1 |
| Takemori, E | 1 |
| Hasegawa, Y | 1 |
| Nakao, N | 1 |
| Inukai, T | 1 |
| Amroian, EA | 1 |
| Vartazarian, ND | 1 |
| Parsamian, LK | 1 |
| Balian, LS | 1 |
| Herrschaft, H | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Escitalopram and Language Intervention for Subacute Aphasia (ELISA)[NCT03843463] | Phase 2 | 88 participants (Anticipated) | Interventional | 2021-07-18 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
5 trials available for piracetam and Anterior Choroidal Artery Infarction
| Article | Year |
|---|---|
Effect of Xuesaitong soft capsule on hemorrheology and in auxiliarily treating patients with acute cerebral infarction.
Topics: Acute Disease; Adult; Aged; Aspirin; Blood Viscosity; Capsules; Cerebral Infarction; Cytidine Diphos | 2005 |
Technetium-99m HMPAO SPET in acute supratentorial ischaemic infarction, expressing deficits as millilitre of zero perfusion.
Topics: Aged; Cerebral Infarction; Cerebrovascular Circulation; Double-Blind Method; Female; Humans; Male; O | 1995 |
Effect of piracetam on recovery and rehabilitation after stroke: a double-blind, placebo-controlled study.
Topics: Aged; Aphasia; Cerebral Infarction; Double-Blind Method; Female; Humans; Male; Middle Aged; Neuropro | 1994 |
The effect of piracetam on the content of glucose in the blood of patients with cerebral infarction at the very early stage of the illness.
Topics: Aged; Aged, 80 and over; Blood Glucose; Cerebral Infarction; Humans; Middle Aged; Piracetam | 1992 |
[The effectiveness of piracetam in acute cerebral ischemia in the human. A clinical controlled double-blind study of piracetam/10% dextran 40 versus 10% dextran 40/placebo].
Topics: Adult; Aged; Aged, 80 and over; Brain Ischemia; Cerebral Infarction; Clinical Trials as Topic; Dextr | 1988 |
10 other studies available for piracetam and Anterior Choroidal Artery Infarction
| Article | Year |
|---|---|
Therapeutic effect of piracetam with nimodipine on vascular dementia after cerebral infarction.
Topics: Aged; Calcium Channel Blockers; Case-Control Studies; Cerebral Infarction; Cerebrovascular Circulati | 2020 |
Unilateral Thalamic Infarct Presenting as a Convulsive Seizure.
Topics: Aspirin; Atorvastatin; Cerebral Angiography; Cerebral Infarction; Humans; Hydrocephalus; Levetiracet | 2017 |
The temporal crescent syndrome.
Topics: Aged; Anticonvulsants; Cerebral Infarction; Epilepsy; Female; Humans; Levetiracetam; Piracetam; Synd | 2015 |
Experience in the use of Actovegin in the treatment of patients with cognitive disorders in the acute period of stroke.
Topics: Aged; Brain Ischemia; Central Nervous System Stimulants; Cerebral Infarction; Cerebrovascular Circul | 2008 |
The 2-oxopyrrolidinacetamide piracetam reduces infarct brain volume induced by permanent middle cerebral artery occlusion in male rats.
Topics: Animals; Cerebral Infarction; Dose-Response Relationship, Drug; Ligation; Male; Middle Cerebral Arte | 2002 |
Influence of the postlesion environment and chronic piracetam treatment on the organization of the somatotopic map in the rat primary somatosensory cortex after focal cortical injury.
Topics: Afferent Pathways; Animals; Brain Injuries; Brain Ischemia; Brain Mapping; Cell Death; Cerebral Infa | 2003 |
[The management of stroke in Phnom Penh, Cambodia].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Aspirin; Brain Ischemia; Calcium Channe | 2007 |
[Carbamazepine poisoning caused by confusing the drugs].
Topics: Adult; Aged; Anticonvulsants; Carbamazepine; Cerebral Infarction; Diagnosis, Differential; Drug Over | 2000 |
Effect of oxiracetam on cerebrovascular impairment in rats.
Topics: Animals; Behavior, Animal; Benzoquinones; Blood Pressure; Cerebral Arteries; Cerebral Infarction; Ce | 1991 |
[Effects of GABA and piracetam on the development of experimental cerebral infarction in rats and platelet aggregation in patients with cerebrovascular disorders].
Topics: Animals; Arachidonic Acid; Arachidonic Acids; Brain; Cerebral Infarction; Cerebrovascular Disorders; | 1990 |